Summerset - Annual Report 2025
Summerset Group Holdings Limited
Provider claim
Community provider
2026-10-10
Next review: 2027-04-10
New Zealand and Australia
High confidence
verified
Primary-source FY25 operator-report audit, 10 October 2026
Evidence boundary: Issuer Annual Report 2025 for the year ended 31 December 2025, explicitly released 27 February 2026. All preserved pages were text-inspected, selected scope, portfolio and financial-table pages visually checked, and the current issuer PDF was byte-matched on 10 October 2026. High confidence concerns identity and sourced cells, not independent validation of company care, satisfaction, staffing, policy or forecast claims. The PwC financial audit does not turn all narrative material into independent clinical evidence. NZ/Australia portfolio care units include beds; retirement units, ORA sales/deliveries, future land-bank capacity and staffed care availability are distinct. IFRS profit and non-GAAP underlying profit have different definitions; FY24 investment-property and profit comparatives are restated. The snapshot gives 676 FY24 ORA units delivered while the five-year table gives 708; this unresolved discrepancy is disclosed, not used for growth claims. The glossary cites a New Zealand Retirement Villages Act 2023, whereas the primary legislation title is Retirement Villages Act 2003; do not reuse the source typo as law. Report projections, construction milestones and continuum-of-care statements are not guarantees of later delivery or individual entitlement. Board/audit date 26 February, release 27 February, June 2026 access and this review are separate. Original filename/year, bytes/hash and category remain preserved; no personalised financial, legal or clinical advice.
Short Answer
Summerset FY2025 company report released February 2026: retirement/care portfolio, delivered occupation-right units, development pipeline, financial results, governance and sustainability; future plans and corporate service claims remain qualified.
Why it matters
Use the report for a dated operator case study and to compare portfolio categories, historical deliveries/sales, IFRS and non-GAAP results, cash-flow definitions and project stages. Keep New Zealand/Australia scope and restated comparatives visible. Verify current care access, charges, certification and project delivery separately.
Key Points
- •FY25 runs from 1 January to 31 December 2025 (physical p.138, printed p.136). The report expressly states release on 27 February 2026 (physical p.2); financial statements were authorised on 26 February 2026 (physical p.57, printed p.55). Filename year and financial year are not publication year.
- •The preserved original has 144 physical PDF pages. The issuer-linked Annual Report 2025 PDF was byte-identical on 10 October 2026; its June 2026 catalogue access history is retained.
- •FY25 company portfolio figures are 7,198 retirement units and 1,475 care units, with the snapshot explicitly stating care units include beds (physical p.6, printed p.4). These are New Zealand/Australia company portfolio categories, not a national ARC-bed count or available staffed places.
- •The report records 693 new occupation-right units delivered in FY25 and 1,560 occupation-right sales, comprising 805 new sales and 755 resales (physical p.52, printed p.50). Deliveries, sales, retirement units and care beds are not interchangeable metrics.
- •The land bank lists 5,499 retirement units and 1,173 care units including beds (physical p.6, printed p.4). These are planned development capacity, not operational or staffed places; the 44-village total includes villages under development.
- •Consolidated FY25 total revenue was NZ$361.774 million and IFRS profit after tax NZ$259.720 million (physical p.54, printed p.52; NZ$000 table). FY24 profit is restated to NZ$331.958 million following an investment-property valuation correction (physical p.64, printed p.62).
Full Summary & Notes
Summerset Group Holdings Limited’s Annual Report 2025 covers 1 January–31 December 2025 and was released on 27 February 2026. The 144-page preserved report combines New Zealand/Australia operational and development narratives, sustainability and governance disclosures with consolidated financial statements and a PwC audit. Company figures report 7,198 retirement units and 1,475 care units, a category that includes beds, plus 693 new occupation-right units delivered during FY25. Consolidated IFRS profit after tax was NZ$259.720 million; the separate non-GAAP underlying-profit measure was NZ$234.153 million. Portfolio stock, sales, future land bank and clinical service availability are different measures.
Read bundled source notes
The saved source file may include fuller notes and references than the indexed summary. Check its dates and evidence limits.
Loading saved source notes…
Document Details & Metadata
Related Resources
Historical FY25 Radius company report: portfolio activity, diversification, development plans, governance and audited group accounts; not a national capacity, staffing or clinical-quality assessment.
Standalone FY25 Ryman consolidated accounts and financial audit, with restated comparatives, New Zealand/Australia segments and valuation/financing notes; financial evidence, not a full annual-report narrative or clinical evaluation.
Historical FY2024 operator report on care occupancy, resident and employee feedback, development, audited financial statements, climate scenarios and governance; underlying profit and care-quality narrative have separate assurance limits.
Historical FY2025 report covering village and co-located care capacity, mixed unit/suite completions, workforce feedback, development plans, emissions accounting and audited financial statements; portfolio excludes the Palmerston North joint venture.
The report brings together a corporate portfolio overview, strategy, resident experience, workforce and environmental initiatives, audited consolidated financial statements and remuneration/governance reporting. Its accounts report a statutory loss despite improved adjusted operating earnings and positive aggregate free cash flow; the existing-operations component of that cash flow remains negative. Restated FY25 values and the note 2 reconciliation are essential for comparisons. Use the company’s dated care occupancy and portfolio figures to frame questions, with mature-site and cross-country boundaries retained. Organisation-wide team members are not clinical staffing FTE; NPS and participation scores lack detailed survey denominators. Testimonials, product roll-outs and training claims are commercial narrative rather than independently evaluated clinical evidence. Future construction, demographic assertions and dividend/funding expectations require separate subsequent verification.
Report-based reconciliation of a June 2026 source brief. Original authored publication date is known only to year 2026; 5 June dates the annual report, not necessarily the brief. Detailed narrative retains historical strategy and June news context while correcting report contradictions; analyst reaction, subsequent bond events and later role/project outcomes are not independently checked in this scoped review.